FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511669211> ?p ?o ?g. }

• W2511669211 endingPage "5202" @default.
• W2511669211 startingPage "5195" @default.
• W2511669211 abstract "Previously, we found that the expression of decoy receptor 3 (DcR3) in gliomas was significantly upregulated compared to normal brain tissues. However, the effect of DcR3-specific small interfering RNA (siRNA) on cell biological function of glioma cells remains incompletely understood.The aim of this study was to explore the effect of DcR3 siRNA on cell growth and apoptosis of glioma cells and to investigate the potential downstream pathways affected by DcR3.DcR3-specific siRNA was transfected into three glioma cell lines (U251MG, LN-308, and U87MG) using combiMAGnetofection method. MTS tetrazolium assay and fluorimetric resorufin viability assay were used to assess the growth of glioma cells. Then, apoptosis was examined using the Hoechst 33342/propidium iodide double-staining assay and fluorescent caspase-3/7 assay. Meanwhile, Western blot was performed to explore the probable pathway by which DcR3-specific siRNA acts in glioma cells. Also, microarray dataset analysis was applied to analyze the potential function of DcR3 in glioma.The DcR3-specific siRNA had a potent effect on cell growth and apoptosis of all three glioma cells tested, and the effects were time dependent. Among these three glioma cell lines, U251MG had the most significant effect with regard to growth inhibition and apoptosis induction. MTS assay showed that the proliferation rate at 72 and 96 hours after the transfection was 76.333%±5.131% (t=7.611, P=0.002) and 64.333%±5.859% (t=10.983, P<0.001), respectively. The viability rate of U251MG cells was 80.667%±2.309% (t=12.302, P<0.001) and 62.333%±2.082% (t=21.213, P<0.001) at 72 and 96 hours posttreatment, respectively. The caspase-3/7 activity of U251MG cells was 2.76 (t=-6.601, P=0.003) and 4.75 (t=-9.189, P=0.001) folds that of the mock control at 72 and 96 hours, respectively. The apoptosis rate was increased to 1.85 (t=-2.496, P=0.067) and 3.93 (t=-12.587, P<0.001) folds at 72 and 96 hours after transfection, respectively. Furthermore, the levels of phospho-ERK1/2 and phospho-AKT were significantly downregulated after DcR3 silencing.The DcR3-specific siRNA could efficiently inhibit growth and induce apoptosis of cells via affecting ERK and AKT. Hence, DcR3-specific siRNA treatment could act as a supplementary targeted therapy strategy for gliomas." @default.
• W2511669211 created "2016-09-16" @default.
• W2511669211 creator A5000325163 @default.
• W2511669211 creator A5003842620 @default.
• W2511669211 creator A5018633041 @default.
• W2511669211 creator A5025275880 @default.
• W2511669211 creator A5039062226 @default.
• W2511669211 creator A5040765195 @default.
• W2511669211 creator A5045067652 @default.
• W2511669211 creator A5063002491 @default.
• W2511669211 creator A5063077523 @default.
• W2511669211 creator A5080784645 @default.
• W2511669211 date "2016-08-01" @default.
• W2511669211 modified "2023-10-14" @default.
• W2511669211 title "Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT" @default.
• W2511669211 cites W1544100339 @default.
• W2511669211 cites W1698416416 @default.
• W2511669211 cites W1895296576 @default.
• W2511669211 cites W1968438421 @default.
• W2511669211 cites W1973165092 @default.
• W2511669211 cites W1977151917 @default.
• W2511669211 cites W1979538859 @default.
• W2511669211 cites W1982716284 @default.
• W2511669211 cites W2008314146 @default.
• W2511669211 cites W2022976025 @default.
• W2511669211 cites W2023231660 @default.
• W2511669211 cites W2040887036 @default.
• W2511669211 cites W2040935952 @default.
• W2511669211 cites W2059978392 @default.
• W2511669211 cites W2060345044 @default.
• W2511669211 cites W2063373586 @default.
• W2511669211 cites W2077833543 @default.
• W2511669211 cites W2084451414 @default.
• W2511669211 cites W2090732607 @default.
• W2511669211 cites W2100989146 @default.
• W2511669211 cites W2114544688 @default.
• W2511669211 cites W2116026300 @default.
• W2511669211 cites W2116178697 @default.
• W2511669211 cites W2128200781 @default.
• W2511669211 cites W2128659329 @default.
• W2511669211 cites W2141216640 @default.
• W2511669211 cites W2157438884 @default.
• W2511669211 cites W2158734599 @default.
• W2511669211 cites W2189496617 @default.
• W2511669211 cites W2406361842 @default.
• W2511669211 doi "https://doi.org/10.2147/ott.s108395" @default.
• W2511669211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5010168" @default.
• W2511669211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27621648" @default.
• W2511669211 hasPublicationYear "2016" @default.
• W2511669211 type Work @default.
• W2511669211 sameAs 2511669211 @default.
• W2511669211 citedByCount "10" @default.
• W2511669211 countsByYear W25116692112017 @default.
• W2511669211 countsByYear W25116692112018 @default.
• W2511669211 countsByYear W25116692112019 @default.
• W2511669211 countsByYear W25116692112020 @default.
• W2511669211 countsByYear W25116692112023 @default.
• W2511669211 crossrefType "journal-article" @default.
• W2511669211 hasAuthorship W2511669211A5000325163 @default.
• W2511669211 hasAuthorship W2511669211A5003842620 @default.
• W2511669211 hasAuthorship W2511669211A5018633041 @default.
• W2511669211 hasAuthorship W2511669211A5025275880 @default.
• W2511669211 hasAuthorship W2511669211A5039062226 @default.
• W2511669211 hasAuthorship W2511669211A5040765195 @default.
• W2511669211 hasAuthorship W2511669211A5045067652 @default.
• W2511669211 hasAuthorship W2511669211A5063002491 @default.
• W2511669211 hasAuthorship W2511669211A5063077523 @default.
• W2511669211 hasAuthorship W2511669211A5080784645 @default.
• W2511669211 hasBestOaLocation W25116692111 @default.
• W2511669211 hasConcept C1491633281 @default.
• W2511669211 hasConcept C153911025 @default.
• W2511669211 hasConcept C185592680 @default.
• W2511669211 hasConcept C190283241 @default.
• W2511669211 hasConcept C22615655 @default.
• W2511669211 hasConcept C2775934118 @default.
• W2511669211 hasConcept C2778227246 @default.
• W2511669211 hasConcept C31573885 @default.
• W2511669211 hasConcept C502942594 @default.
• W2511669211 hasConcept C53227056 @default.
• W2511669211 hasConcept C54009773 @default.
• W2511669211 hasConcept C54355233 @default.
• W2511669211 hasConcept C55493867 @default.
• W2511669211 hasConcept C57074206 @default.
• W2511669211 hasConcept C62112901 @default.
• W2511669211 hasConcept C62478195 @default.
• W2511669211 hasConcept C75217442 @default.
• W2511669211 hasConcept C81885089 @default.
• W2511669211 hasConcept C86803240 @default.
• W2511669211 hasConcept C95444343 @default.
• W2511669211 hasConceptScore W2511669211C1491633281 @default.
• W2511669211 hasConceptScore W2511669211C153911025 @default.
• W2511669211 hasConceptScore W2511669211C185592680 @default.
• W2511669211 hasConceptScore W2511669211C190283241 @default.
• W2511669211 hasConceptScore W2511669211C22615655 @default.
• W2511669211 hasConceptScore W2511669211C2775934118 @default.
• W2511669211 hasConceptScore W2511669211C2778227246 @default.
• W2511669211 hasConceptScore W2511669211C31573885 @default.
• W2511669211 hasConceptScore W2511669211C502942594 @default.

• next